- Home
- E vs PRME Comparison
E vs PRME Comparison
Compare E & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | E | PRME |
|---|---|---|
| Founded | 1953 | 2019 |
| Country | Italy | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medicinal Chemicals and Botanical Products |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.0B | 601.1M |
| IPO Year | 1995 | 2022 |
Fundamental Metrics
Financial Performance| Metric | E | PRME |
|---|---|---|
| Price | $37.53 | $4.16 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 6 |
| Target Price | ★ $31.60 | $9.31 |
| AVG Volume (30 Days) | 229.1K | ★ 3.7M |
| Earning Date | 10-24-2025 | 11-07-2025 |
| Dividend Yield | ★ 4.27% | N/A |
| EPS Growth | ★ 7.76 | N/A |
| EPS | ★ 0.96 | N/A |
| Revenue | ★ $101,555,790,226.00 | $5,977,000.00 |
| Revenue This Year | N/A | $111.80 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $18.49 | ★ N/A |
| Revenue Growth | N/A | ★ 647.13 |
| 52 Week Low | $24.65 | $1.11 |
| 52 Week High | $38.47 | $6.94 |
Technical Indicators
Market Signals| Indicator | E | PRME |
|---|---|---|
| Relative Strength Index (RSI) | 53.67 | 52.01 |
| Support Level | $37.27 | $3.95 |
| Resistance Level | $38.27 | $4.42 |
| Average True Range (ATR) | 0.35 | 0.30 |
| MACD | -0.07 | 0.12 |
| Stochastic Oscillator | 66.12 | 76.72 |
Price Performance
Historical ComparisonAbout E ENI S.p.A.
Eni is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2024, the company produced 0.8 million barrels of liquids and 4.8 billion cubic feet of natural gas per day. At end-2024, Eni held reserves of 6.5 billion barrels of oil equivalent, 46% of which are liquids. The Italian government owns a 30.5% stake in the company. Eni is placing its renewable and low-carbon business in a separate entity called Plenitude, which it will likely list publicly at some point.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.